发明申请
- 专利标题： Pyrimidine derivatives
- 专利标题（中）： 嘧啶衍生物
-
申请号： US11313380申请日： 2005-12-21
-
公开(公告)号： US20060100211A1公开(公告)日： 2006-05-11
- 发明人: Georg Dahmann , Frank Himmelsbach , Bernd Krist , Martin Lenter , Alexander Pautsch , Gisela Schnapp , Martin Steegmaier , Helmut Wittneben , Anthony Prokopowicz , Walter Spevak , Andreas Schoop , Steffen Steurer
- 申请人： Georg Dahmann , Frank Himmelsbach , Bernd Krist , Martin Lenter , Alexander Pautsch , Gisela Schnapp , Martin Steegmaier , Helmut Wittneben , Anthony Prokopowicz , Walter Spevak , Andreas Schoop , Steffen Steurer
- 申请人地址： DE Ingelheim
- 专利权人： Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人： Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人地址： DE Ingelheim
- 主分类号： C07D403/02
- IPC分类号： C07D403/02 ; A61K31/501 ; A61K31/506
摘要：
The present invention relates to trisubstituted pyrimidines of formula (I) wherein 0Ra to Re are defined as in claim 1, which are suitable for the treatment of illnesses characterised by excessive or abnormal cell proliferation, the use thereof for preparing a pharmaceutical composition with the abovementioned properties, and processes for the preparation thereof.
公开/授权文献
- US07709480B2 Pyrimidine derivatives 公开/授权日：2010-05-04